<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> (BWS) is a congenital <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-predisposition syndrome associated with <z:e sem="disease" ids="C0751364" disease_type="Neoplastic Process" abbrv="">embryonal cancers</z:e>, <z:hpo ids='HP_0000158'>macroglossia</z:hpo>, <z:hpo ids='HP_0001520'>macrosomia</z:hpo>, ear pits or ear creases, and midline <z:hpo ids='HP_0010866'>abdominal-wall defects</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The most common constitutional abnormalities in BWS are epigenetic, involving abnormal methylation of either H19 or LIT1, which encode untranslated <z:chebi fb="40" ids="33697">RNAs</z:chebi> on 11p15 </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that different epigenetic alterations would be associated with specific phenotypes in BWS </plain></SENT>
<SENT sid="3" pm="."><plain>To test this hypothesis, we performed a case-cohort study, using the BWS Registry </plain></SENT>
<SENT sid="4" pm="."><plain>The cohort consisted of 92 patients with BWS and molecular analysis of both H19 and LIT1, and these patients showed the same frequency of clinical phenotypes as those patients in the Registry from whom biological samples were not available </plain></SENT>
<SENT sid="5" pm="."><plain>The frequency of altered DNA methylation of H19 in patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was significantly higher, 56% (9/16), than the frequency in patients without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, 17% (13/76; P=.002), and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was not associated with LIT1 alterations </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, the frequency of altered DNA methylation of LIT1 in patients with midline <z:hpo ids='HP_0010866'>abdominal-wall defects</z:hpo> and <z:hpo ids='HP_0001520'>macrosomia</z:hpo> was significantly higher, 65% (41/63) and 60% (46/77), respectively, than in patients without such defects, 34% (10/29) and 18% (2/11), respectively (P=.012 and P=.02, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Additionally, paternal <z:mp ids='MP_0008867'>uniparental disomy</z:mp> (UPD) of 11p15 was associated with <z:hpo ids='HP_0001528'>hemihypertrophy</z:hpo> (P=.003), <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (P=.03), and <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> (P=.05) </plain></SENT>
<SENT sid="8" pm="."><plain>These results define an epigenotype-phenotype relationship in BWS, in which aberrant methylation of H19 and LIT1 and UPD are strongly associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk and specific birth defects </plain></SENT>
</text></document>